5th Cir. Upholds Dismissal of Medtronic Defibrillator Case on Preemption Grounds



DOCUMENTS
  • Opinion


NEW ORLEANS — A federal appellate panel has refused to reinstate a Louisiana man’s lawsuit targeting Medtronic’s implantable defibrillator, affirming that the claims are preempted by federal law because they attack the device’s Food and Drug Administration-approved manufacturing process.

In an Oct. 18 opinion, the 5th Circuit U.S. Court of Appeals panel found the plaintiff failed to adequately plead violations of state law that parallel federal regulations. Instead, he “makes numerous conclusory allegations” that the device is unreasonably dangerous, the panel found.

Plaintiff Matthew Naquin has a history of heart problems. His cardiologist recommended a Medtronic Evera XT VR …






UPCOMING CONFERENCES




HarrisMartin’s Webinar Series: Infant Formula & Necrotizing Enterocolitis (NEC) Litigation

January 11, 2022 - None, None
None

MORE DETAILS



HarrisMartin’s Philips CPAP, BiPAP & Ventilator MDL Conference

December 14, 2021 - Pittsburgh, PA
The Omni William Penn Hotel

MORE DETAILS